COLD LIGHT; COLD LIGHT MD; GOSSAMER DERMLIGHT

K041679 · Onyx Medical, Inc. · ILY · Dec 16, 2004 · Physical Medicine

Device Facts

Record IDK041679
Device NameCOLD LIGHT; COLD LIGHT MD; GOSSAMER DERMLIGHT
ApplicantOnyx Medical, Inc.
Product CodeILY · Physical Medicine
Decision DateDec 16, 2004
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 890.5500
Device ClassClass 2
AttributesTherapeutic

Indications for Use

To provide topical heating for the temporary rellef of minor muscle and foint pains and stiffness, the temporary relief of minor joint pain assoclated with arthritls, the temporary Increase In local blood clrculation where applied, the relaxation of muscles, and help muscle spasms, minor sprains and strains, and minor muscular back paln.

Device Story

Cold Light, Cold Light MD, and Gossamer Dermlight are infrared lamps providing topical heating. Devices operate by emitting infrared energy to the skin surface. Used in home or clinical settings by patients or clinicians for temporary pain relief, increased local circulation, and muscle relaxation. Output is thermal energy; healthcare providers or patients apply device to affected area to alleviate symptoms of minor musculoskeletal conditions.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Infrared lamp; 21 CFR 890.5500; Product Code ILY. Device utilizes infrared energy for topical heating. No specific materials, dimensions, or software algorithms described.

Indications for Use

Indicated for OTC use for temporary relief of minor muscle/joint pain, stiffness, arthritis-associated joint pain, muscle spasms, minor sprains/strains, and minor muscular back pain; also indicated to increase local blood circulation and promote muscle relaxation.

Regulatory Classification

Identification

An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.

Special Controls

*Classification.* Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

Submission Summary (Full Text)

{0}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized design of three human profiles facing right, stacked on top of each other. The profiles are connected by flowing lines, creating a sense of unity and movement. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the design. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## FEB 1 7 2005 Mr. Roger Machson President Onyx Medical, Inc. 445 Coloma Street Sausalito, California 94965 Re: K041679 Trade/Device Name: Cold Light; Cold Light MD; and Gossamer Dermlight Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: II Product Code: ILY Dated: October 26, 2004 Received: October 28, 2004 Dear Mr. Machson: This letter corrects our substantially equivalent letter of December 16, 2004 regarding the Indications for Use page. The device should be OTC, not Prescription. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. {1}------------------------------------------------ ## Page 2 - Mr. Roger Machson This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Muriam C. Provost Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number: K041679 Cold Light; Cold Light MD; and Gossamer Dermlight Device Name(s): Indications For Use: The Cold Light, Cold Light MD, and Gossamer DermLight are indicated for use as follows: To provide topical heating for the temporary rellef of minor muscle and foint pains and stiffness, the temporary relief of minor joint pain assoclated with arthritls, the temporary Increase In local blood clrculation where applied, the relaxation of muscles, and help muscle spasms, minor sprains and strains, and minor muscular back paln. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of _ Muriam C. Provost (Division Sign-Off) Division of General, Restorative, and Neurological Devices RO41619 510(k) Number
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...